glp 1 drugs shortage Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Taking Stock: What Ro's GLP-1
Description
EZGLP1T-36K

Antibody Blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism

Several trials have demonstrated that GLP-1 RAs reduce cardiovascular risk in patients with type 2 diabetes mellitus and ASCVD or high cardiovascular risk and have beneficial effects on cardio-renal outcomes beyond their blood glucose-lowering effects in type 2 diabetes mellitus patients

Additionally, this medication is also FDA-approved for the treatment of moderate to severe obstructive sleep apnea in adults

~, unchanged compared to placebo
